WASHINGTON (AP) - Scientists for the Food and Drug Administration say an Amgen drug slowed the spread of cancer to the bone in men with hard-to-treat prostate cancer, though the drug failed to extend life and carried significant side effects.
Back
Health 
Health News Men's Health
Health News Men's Health
Men's Health
FDA question's Amgen drug for prostate cancer
- February 06 2012
- Associated Press
Moustaches Can Promote Cancer Awareness
- November 01 2011
- administrator
Wyoming men are being asked by the Wyoming Comprehensive Cancer Control Consortium to commit to growing a moustache for 30 days starting November 1 as part of a men’s health promotion effort called “Movember.”
NEW: Study: Prostate cancer surgery helps younger men
- May 05 2011
- Associated Press
(AP) - A study suggests that men under 65 with early prostate cancer have better survival odds if they have surgery right away instead of waiting for treatment.
Study: PSA rise not good prostate cancer predictor
- February 25 2011
- Associated Press
WASHINGTON (AP) - A major study finds that a rising PSA level isn't such a good predictor of prostate cancer after all and can lead to many unnecessary biopsies.
Men with ED Demonstrate Increased Risk of Calcified Coronary Arteries
- January 20 2011
- administrator
NEW YORK, NY - In the largest study done to date, RMA of New York's Dr. Natan Bar-Chama and his associates presented ground-breaking research that determined men with erectile dysfunction (ED) are at a significantly increased risk of high coronary artery calcification scores (CACS), a known predictor of future cardiovascular events.
